IDH1 and central nervous system cancer: Regarding glioma subtype-specific clinical implications, we found that ESURATAG-GS expression is associated with higher tumor grade in IDH1-Mut tumors (Figure 9I), ODGs (Figure 9J), ATCs (Figure 9K) and IDH1-WT tumors (Figure 9L) in TCGA dataset.